NCT05496036
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Penn Medicine Philadelphia, Pennsylvania, United States
Clinical trial condition
Carcinoma, Merkel Cell
Explore clinical trials studying Carcinoma, Merkel Cell. Study availability and eligibility vary by location and protocol.
103 public trials
29 recruiting studies
Carcinoma, Merkel Cell trial results
NCT06151236
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
Recruiting
TIL Therapy in cSCC and MCC
NCT07288073
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +21 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05859074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Sebaceous, Adnexal Carcinoma, +58 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
NCT06940440
- Conditions
- Adenocarcinoma, Advanced Or Metastatic Merkel Cell Carcinoma, Carcinoma, +18 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
Recruiting
Personalised Immunotherapy Platform
NCT06536257
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +25 more
- Locations
-
- Chris O'Brien Lifehouse Sydney, New South Wales, Australia
- Melanoma Institute Australia Sydney, New South Wales, Australia
- Westmead Hospital Sydney, New South Wales, Australia
NCT05592626
- Conditions
- Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +89 more
- Locations
-
- Loma Linda University Cancer Center Loma Linda, California, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- AdventHealth Celebration Celebration, Florida, United States
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692
- Conditions
- Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
- Locations
-
- Sharp Memorial Hospital San Diego, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Providence Saint John's Health Center Santa Monica, California, United States
- Boca Raton Regional Hospital Boca Raton, Florida, United States
NCT05797415
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Gustavo Savino Roma, Rome, Italy
Not Yet Recruiting
ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
NCT07472322
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- University of Wisconsin-Carbone Cancer Center Madison, Wisconsin, United States